Technical Analysis for GBIO - Generation Bio Co.

Grade Last Price % Change Price Change
F 1.35 -2.88% -0.04
GBIO closed down 2.88 percent on Wednesday, November 20, 2024, on 1.45 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction -2.88%
Narrow Range Bar Range Contraction -2.88%
Lower Bollinger Band Walk Weakness -2.88%

   Recent Intraday Alerts

Alert Time
Rose Above Lower Bollinger Band about 22 hours ago
Down 1% about 22 hours ago
Possible NR7 1 day ago
60 Minute Opening Range Breakdown 2 days ago
Down 3% 2 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Generation Bio Co. Description

Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues, and to be redosable for individualized and extended treatment throughout a patient’s life. The platform is designed to expand access to treatments for rare diseases and to address prevalent diseases through efficient, scalable manufacturing.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Rare Diseases Molecular Biology Gene Therapy Manufacturing Process Lipid Applied Genetics Gene Delivery

Is GBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.65
52 Week Low 1.1
Average Volume 129,194
200-Day Moving Average 2.75
50-Day Moving Average 2.29
20-Day Moving Average 2.03
10-Day Moving Average 1.81
Average True Range 0.20
RSI (14) 24.24
ADX 30.99
+DI 8.89
-DI 36.45
Chandelier Exit (Long, 3 ATRs) 1.97
Chandelier Exit (Short, 3 ATRs) 1.89
Upper Bollinger Bands 2.73
Lower Bollinger Band 1.33
Percent B (%b) 0.01
BandWidth 68.61
MACD Line -0.24
MACD Signal Line -0.15
MACD Histogram -0.0888
Fundamentals Value
Market Cap 89.21 Million
Num Shares 66.1 Million
EPS -1.97
Price-to-Earnings (P/E) Ratio -0.69
Price-to-Sales 46.08
Price-to-Book 0.57
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.61
Resistance 3 (R3) 1.61 1.54 1.56
Resistance 2 (R2) 1.54 1.47 1.53 1.55
Resistance 1 (R1) 1.44 1.43 1.41 1.44 1.53
Pivot Point 1.37 1.37 1.35 1.36 1.37
Support 1 (S1) 1.27 1.30 1.24 1.27 1.17
Support 2 (S2) 1.20 1.26 1.19 1.15
Support 3 (S3) 1.10 1.20 1.14
Support 4 (S4) 1.10